Farmaceutica REMEDIA S.A.

BVB:RMAH Stock Report

Market Cap: RON 62.7m

Farmaceutica REMEDIA Dividends and Buybacks

Dividend criteria checks 3/6

Farmaceutica REMEDIA is a dividend paying company with a current yield of 6.04% that is well covered by earnings. Next payment date is on 30th September, 2025 with an ex-dividend date of 11th September, 2025.

Key information

6.0%

Dividend yield

0%

Buyback Yield

Total Shareholder Yield6.0%
Future Dividend Yieldn/a
Dividend Growth4.9%
Next dividend pay date30 Sep 25
Ex dividend date11 Sep 25
Dividend per sharen/a
Payout ratio45%

Recent dividend and buyback updates

Farmaceutica REMEDIA's (BVB:RMAH) Dividend Will Be Reduced To RON0.04

Mar 23
Farmaceutica REMEDIA's (BVB:RMAH) Dividend Will Be Reduced To RON0.04

Recent updates

Farmaceutica REMEDIA's (BVB:RMAH) Dividend Will Be Reduced To RON0.04

Mar 23
Farmaceutica REMEDIA's (BVB:RMAH) Dividend Will Be Reduced To RON0.04

Farmaceutica REMEDIA's (BVB:RMAH) Soft Earnings Are Actually Better Than They Appear

Mar 06
Farmaceutica REMEDIA's (BVB:RMAH) Soft Earnings Are Actually Better Than They Appear

Returns At Farmaceutica REMEDIA (BVB:RMAH) Are On The Way Up

Mar 04
Returns At Farmaceutica REMEDIA (BVB:RMAH) Are On The Way Up

Farmaceutica REMEDIA's (BVB:RMAH) Returns On Capital Are Heading Higher

Mar 07
Farmaceutica REMEDIA's (BVB:RMAH) Returns On Capital Are Heading Higher

Returns Are Gaining Momentum At Farmaceutica REMEDIA (BVB:RMAH)

Aug 18
Returns Are Gaining Momentum At Farmaceutica REMEDIA (BVB:RMAH)

We Like These Underlying Return On Capital Trends At Farmaceutica REMEDIA (BVB:RMAH)

Mar 23
We Like These Underlying Return On Capital Trends At Farmaceutica REMEDIA (BVB:RMAH)

Does Farmaceutica REMEDIA (BVB:RMAH) Deserve A Spot On Your Watchlist?

Feb 16
Does Farmaceutica REMEDIA (BVB:RMAH) Deserve A Spot On Your Watchlist?

Is There More To The Story Than Farmaceutica REMEDIA's (BVB:RMAH) Earnings Growth?

Jan 15
Is There More To The Story Than Farmaceutica REMEDIA's (BVB:RMAH) Earnings Growth?

Is Farmaceutica REMEDIA S.A.'s (BVB:RMAH) Recent Performance Tethered To Its Attractive Financial Prospects?

Dec 16
Is Farmaceutica REMEDIA S.A.'s (BVB:RMAH) Recent Performance Tethered To Its Attractive Financial Prospects?

Should You Invest In Farmaceutica REMEDIA (BVB:RMAH)?

Nov 18
Should You Invest In Farmaceutica REMEDIA (BVB:RMAH)?

Upcoming Dividend Payment

TodayMay 21 2025Ex Dividend DateSep 11 2025Dividend Pay DateSep 30 202519 days from Ex DividendBuy in the next 112 days to receive the upcoming dividend

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: RMAH's dividend payments have been volatile in the past 10 years.

Growing Dividend: RMAH's dividend payments have increased over the past 10 years.

Dividend Yield vs Market

Farmaceutica REMEDIA Dividend Yield vs Market
How does RMAH dividend yield compare to the market?
SegmentDividend Yield
Company (RMAH)6.0%
Market Bottom 25% (RO)2.4%
Market Top 25% (RO)6.7%
Industry Average (Consumer Retailing)3.5%
Analyst forecast (RMAH) (up to 3 years)n/a

Notable Dividend: RMAH's dividend (6.04%) is higher than the bottom 25% of dividend payers in the RO market (2.48%).

High Dividend: RMAH's dividend (6.04%) is low compared to the top 25% of dividend payers in the RO market (6.59%).

Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (44.9%), RMAH's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (99.5%), RMAH's dividend payments are not well covered by cash flows.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/20 08:49
End of Day Share Price 2025/05/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Farmaceutica REMEDIA S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Virgil LivanovFairwind Consulting